These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22027787)

  • 1. [Evaluation of two arterial closure devices, Angioseal and Perclose, in coronary catheter interventions].
    Zhou ZJ; Cui K; Cao SP; Huang Z; Guo ZG; Xiu JC; Hou YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1767-70. PubMed ID: 22027787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices.
    Duffin DC; Muhlestein JB; Allisson SB; Horne BD; Fowles RE; Sorensen SG; Revenaugh JR; Bair TL; Lappe DL
    J Invasive Cardiol; 2001 May; 13(5):354-62. PubMed ID: 11385148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inflammatory response to femoral arterial closure devices: a randomized comparison among FemoStop, AngioSeal, and Perclose.
    Jensen J; Saleh N; Jensen U; Svane B; Jönsson A; Tornvall P
    Cardiovasc Intervent Radiol; 2008; 31(4):751-5. PubMed ID: 18398639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized trial comparing the safety and efficacy of three commercially available closure devices (Angioseal, Vasoseal and Duett).
    Michalis LK; Rees MR; Patsouras D; Katsouras CS; Goudevenos J; Pappas S; Sourla E; Kolettis T; Sioros L; Zotou P; Gartzou-Matsouka P; Sideris DA
    Cardiovasc Intervent Radiol; 2002; 25(5):423-9. PubMed ID: 12132030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of Vasoseal and Angioseal closure devices in patients undergoing coronary angiography and angioplasty.
    Shammas NW; Rajendran VR; Alldredge SG; Witcik WJ; Robken JA; Lewis JR; McKinney D; Hansen CA; Kabel ME; Harris M; Jerin MJ; Bontu PR; Dippel EJ; Labroo A
    Catheter Cardiovasc Interv; 2002 Apr; 55(4):421-5. PubMed ID: 11948884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angioseal VIP® vs. StarClose SE® closure devices: a comparative analysis in non-cardiological procedures.
    Lucatelli P; Fanelli F; Cannavale A; Corona M; Cirelli C; D'Adamo A; Salvatori FM; Catalano C
    J Cardiovasc Surg (Torino); 2017 Feb; 58(1):80-86. PubMed ID: 24309473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of the Angioseal device for femoral artery closure.
    Abando A; Hood D; Weaver F; Katz S
    J Vasc Surg; 2004 Aug; 40(2):287-90. PubMed ID: 15297822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices.
    Assali AR; Sdringola S; Moustapha A; Ghani M; Salloum J; Schroth G; Fujise K; Anderson HV; Smalling RW; Rosales OR
    Catheter Cardiovasc Interv; 2003 Jan; 58(1):1-5. PubMed ID: 12508187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial comparing compression, Perclose Proglide and Angio-Seal VIP for arterial closure following percutaneous coronary intervention: the CAP trial.
    Martin JL; Pratsos A; Magargee E; Mayhew K; Pensyl C; Nunn M; Day F; Shapiro T
    Catheter Cardiovasc Interv; 2008 Jan; 71(1):1-5. PubMed ID: 18098171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vascular complications at the femoral access: impact of the percutaneous closure device Perclose].
    Mboup MC; Moquet B; Zabalawi A; Delaunay R
    Ann Cardiol Angeiol (Paris); 2014 Apr; 63(2):71-4. PubMed ID: 24613004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous femoral closure following stent-graft placement: use of the Perclose device.
    Quinn SF; Kim J
    Cardiovasc Intervent Radiol; 2004; 27(3):231-6. PubMed ID: 15037951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of the angioseal vascular closure device post antegrade puncture.
    Looby S; Keeling AN; McErlean A; Given MF; Geoghegan T; Lee MJ
    Cardiovasc Intervent Radiol; 2008; 31(3):558-62. PubMed ID: 18253787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro).
    Chamberlin JR; Lardi AB; McKeever LS; Wang MH; Ramadurai G; Grunenwald P; Towne WP; Grassman ED; Leya FS; Lewis BE; Stein LH
    Catheter Cardiovasc Interv; 1999 Jun; 47(2):143-7; discussion 148. PubMed ID: 10376492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety and efficacy of "pre-closure" utilizing the Closer suture-mediated vascular closure device for achievement of hemostasis in patients following coronary interventions: results of the second Perclose Accelerated Ambulation and Discharge (PARADISE II) Trial.
    Nasu K; Tsuchikane E; Sumitsuji S; Tsuji T; Tamai H
    J Invasive Cardiol; 2005 Jan; 17(1):30-3. PubMed ID: 15640537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular complications after percutaneous coronary intervention following hemostasis with the Mynx vascular closure device versus the AngioSeal vascular closure device.
    Azmoon S; Pucillo AL; Aronow WS; Ebrahimi R; Vozzolo J; Rajdev A; Kalapatapu K; Ro JH; Hjemdahl-Monsen C
    J Invasive Cardiol; 2010 Apr; 22(4):175-8. PubMed ID: 20351388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practices and complications of vascular closure devices and manual compression in patients undergoing elective transfemoral coronary procedures.
    Smilowitz NR; Kirtane AJ; Guiry M; Gray WA; Dolcimascolo P; Querijero M; Echeverry C; Kalcheva N; Flores B; Singh VP; Rabbani L; Kodali S; Collins MB; Leon MB; Moses JW; Weisz G
    Am J Cardiol; 2012 Jul; 110(2):177-82. PubMed ID: 22482861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and effectiveness of repeat arterial closure using the AngioSeal device in patients with hepatic malignancy.
    Hieb RA; Neisen MJ; Hohenwalter EJ; Molnar JA; Rilling WS
    J Vasc Interv Radiol; 2008 Dec; 19(12):1704-8. PubMed ID: 18951046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised controlled trial comparing StarClose and AngioSeal vascular closure devices in a district general hospital--the SCOAST study.
    Veasey RA; Large JK; Silberbauer J; Paul G; Taggu W; Ellery S; Rathore VS; Lloyd GW; Patel NR; Sulke AN
    Int J Clin Pract; 2008 Jun; 62(6):912-8. PubMed ID: 18479284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty.
    Sanborn TA; Gibbs HH; Brinker JA; Knopf WD; Kosinski EJ; Roubin GS
    J Am Coll Cardiol; 1993 Nov; 22(5):1273-9. PubMed ID: 8227779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off-label use of the Angioseal vascular closure device for femoral arteriotomy: retrospective analysis of safety and efficacy.
    Shah SS; Perez G; Snelling BM; Haussen DC; Sur S; Sharma I; Yavagal DR; Elhammady MS; Peterson EC
    J Neurointerv Surg; 2017 Oct; 9(10):982-985. PubMed ID: 27679537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.